NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/21/2024
Back to search
Official data from USPTO
IVERMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/21/2024
Trademark type
Word
Nice classes
5
Filing date
03/18/2022
Registration date
05/21/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/21/2024
Last transaction
05/21/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/18/2022
First use in commerce
12/01/2023
Drawing code
4
Owner type
03
Owner location
Lewes, DE
Examiner
MCDOWELL, MATTHEW
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Right2Try Inc.
Representatives
Ashley D. Johnson DOGWOOD PATENT AND TRADEMARK LAW
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical compositions and medicaments for use in treatment of cancer; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subjectinhibiting the proliferationmetastasis and angiogenic activity of malignant cells; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subjectregulation of one or more kinase signaling pathwayreversing multi-drug resistanceinhibiting tumor stem cells; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subjectproviding anti-inflammatory and antiviral properties; Pharmaceutical compositions and medicaments for use in the treatment of cancer
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/21/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/12/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/11/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/04/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/04/2024
IUAF
USE AMENDMENT FILED
02/12/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/12/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/25/2023
PUBO
PUBLISHED FOR OPPOSITION
07/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/14/2023
GNRT
NON-FINAL ACTION E-MAILED
04/14/2023
CNRT
NON-FINAL ACTION WRITTEN
04/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/15/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/15/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/15/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/30/2022
GNRT
NON-FINAL ACTION E-MAILED
12/30/2022
CNRT
NON-FINAL ACTION WRITTEN
12/30/2022
DOCK
ASSIGNED TO EXAMINER
12/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/24/2022
Continuous trademark protection
Get notified about every new filing that threatens IVERMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.